Brief histories Archives - The James Lind Library The James Lind Library

Glasziou P, Matthews R, Boutron I, Chalmers I, Armitage P† (2023)
The differences and overlaps between ‘explanatory’ and ‘pragmatic’ controlled trials: a historical perspective. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Lee A (2022).
The development of network meta-analysis. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Brinkmann R, Podolsky SH (2021).
The ‘Personal Equation’ as observer bias, and proposed methods to contain it in Anglo-American medicine. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Clarke M (2021).
The true meaning of DICE: Don’t Ignore Chance Effects JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Matthews RAJ (2020).
The origins of the treatment of uncertainty in clinical medicine. Part 1: Ancient roots, familiar disputes. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Trahair B, Peters L (2020).
James Lind’s descendants. 2nd edition (supersedes Peters L 2006). JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Matthews RAJ (2020).
The origins of the treatment of uncertainty in clinical medicine. Part 2: the emergence of probability theory and its limitations. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Tröhler U (2020)
Probabilistic thinking and the evaluation of therapies, 1700-1900. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Johnson A† (2019).
Textbooks and other publications on controlled clinical trials, 1948 to 1983. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Chalmers I (2019).
Doug Altman’s prescience in recognizing the need to reduce biases before tackling imprecision in Systematic Reviews. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Mirza RD, Punja S, Vohra S, Guyatt G (2017).
The history and development of N of 1 trials. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Wartolowska K, Beard DJ, Carr AJ (2017).
The use of placebos in controlled trials of surgical interventions: a brief history. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Gachelin G, Garner P, Ferroni E, Tröhler U, Chalmers I (2016).
Evaluating Cinchona bark and quinine for treating and preventing malaria. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Clarke M (2015).
History of evidence synthesis to assess treatment effects: personal reflections on something that is very much alive. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Altman DG†, Simera I (2015).
A history of the evolution of guidelines for reporting medical research: the long road to the EQUATOR Network. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Marušić A, Fatović-Ferenčić S (2012).
Adoption of the double dummy trial design to reduce observer bias in testing treatments. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Kaptchuk TJ (2011).
A brief history of the evolution of methods to control observer biases in tests of treatments. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Dickersin K, Chalmers I (2010).
Recognising, investigating and dealing with incomplete and biased reporting of clinical research: from Francis Bacon to the World Health Organisation. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Tröhler U (2010).
The introduction of numerical methods to assess the effects of medical interventions during the 18th century: a brief history. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

O'Rourke K (2006).
A historical perspective on meta-analysis: dealing quantitatively with varying study results. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Armitage P† (2003).
Some recollections of the early years of the Medical Research Council (MRC) Statistical Research Unit. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Silverman WA†, Chalmers I (2002).
Casting and drawing lots: a time-honoured way of dealing with uncertainty and for ensuring fairness. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

James Lind Library
Illustrating the development of fair tests of treatments in health care

ARTICLES — HISTORIES

SORT date ▼ author clear filters

22 ARTICLES

Show

Glasziou P, Matthews R, Boutron I, Chalmers I, Armitage P† (2023)
The differences and overlaps between ‘explanatory’ and ‘pragmatic’ controlled trials: a historical perspective. JLL Bulletin: Commentaries on the history of treatment evaluation.

Lee A (2022).
The development of network meta-analysis. JLL Bulletin: Commentaries on the history of treatment evaluation.

Brinkmann R, Podolsky SH (2021).
The ‘Personal Equation’ as observer bias, and proposed methods to contain it in Anglo-American medicine. JLL Bulletin: Commentaries on the history of treatment evaluation.

Clarke M (2021).
The true meaning of DICE: Don’t Ignore Chance Effects JLL Bulletin: Commentaries on the history of treatment evaluation.

Matthews RAJ (2020).
The origins of the treatment of uncertainty in clinical medicine. Part 1: Ancient roots, familiar disputes. JLL Bulletin: Commentaries on the history of treatment evaluation.

Trahair B, Peters L (2020).
James Lind’s descendants. 2nd edition (supersedes Peters L 2006). JLL Bulletin: Commentaries on the history of treatment evaluation.

Matthews RAJ (2020).
The origins of the treatment of uncertainty in clinical medicine. Part 2: the emergence of probability theory and its limitations. JLL Bulletin: Commentaries on the history of treatment evaluation.

Tröhler U (2020)
Probabilistic thinking and the evaluation of therapies, 1700-1900. JLL Bulletin: Commentaries on the history of treatment evaluation.

Johnson A† (2019).
Textbooks and other publications on controlled clinical trials, 1948 to 1983. JLL Bulletin: Commentaries on the history of treatment evaluation.

Chalmers I (2019).
Doug Altman’s prescience in recognizing the need to reduce biases before tackling imprecision in Systematic Reviews. JLL Bulletin: Commentaries on the history of treatment evaluation.

Mirza RD, Punja S, Vohra S, Guyatt G (2017).
The history and development of N of 1 trials. JLL Bulletin: Commentaries on the history of treatment evaluation.

Wartolowska K, Beard DJ, Carr AJ (2017).
The use of placebos in controlled trials of surgical interventions: a brief history. JLL Bulletin: Commentaries on the history of treatment evaluation.

Gachelin G, Garner P, Ferroni E, Tröhler U, Chalmers I (2016).
Evaluating Cinchona bark and quinine for treating and preventing malaria. JLL Bulletin: Commentaries on the history of treatment evaluation.

Clarke M (2015).
History of evidence synthesis to assess treatment effects: personal reflections on something that is very much alive. JLL Bulletin: Commentaries on the history of treatment evaluation.

Altman DG†, Simera I (2015).
A history of the evolution of guidelines for reporting medical research: the long road to the EQUATOR Network. JLL Bulletin: Commentaries on the history of treatment evaluation.

Marušić A, Fatović-Ferenčić S (2012).
Adoption of the double dummy trial design to reduce observer bias in testing treatments. JLL Bulletin: Commentaries on the history of treatment evaluation.

Kaptchuk TJ (2011).
A brief history of the evolution of methods to control observer biases in tests of treatments. JLL Bulletin: Commentaries on the history of treatment evaluation.

Dickersin K, Chalmers I (2010).
Recognising, investigating and dealing with incomplete and biased reporting of clinical research: from Francis Bacon to the World Health Organisation. JLL Bulletin: Commentaries on the history of treatment evaluation.

Tröhler U (2010).
The introduction of numerical methods to assess the effects of medical interventions during the 18th century: a brief history. JLL Bulletin: Commentaries on the history of treatment evaluation.

O'Rourke K (2006).
A historical perspective on meta-analysis: dealing quantitatively with varying study results. JLL Bulletin: Commentaries on the history of treatment evaluation.

Armitage P† (2003).
Some recollections of the early years of the Medical Research Council (MRC) Statistical Research Unit. JLL Bulletin: Commentaries on the history of treatment evaluation.

Silverman WA†, Chalmers I (2002).
Casting and drawing lots: a time-honoured way of dealing with uncertainty and for ensuring fairness. JLL Bulletin: Commentaries on the history of treatment evaluation.

ALL ARTICLES

BROWSE

ABOUT

COPYRIGHT

FEEDBACK

James Lind LibraryIllustrating the development of fair tests of treatments in health care

ARTICLES — HISTORIES

SORT date ▼ author clear filters

22 ARTICLES

Show ALL ARTICLES Brief histories Commentaries Biographies Personal reflections Doctoral theses

Glasziou P, Matthews R, Boutron I, Chalmers I, Armitage P† (2023)The differences and overlaps between ‘explanatory’ and ‘pragmatic’ controlled trials: a historical perspective. JLL Bulletin: Commentaries on the history of treatment evaluation.

Lee A (2022).The development of network meta-analysis. JLL Bulletin: Commentaries on the history of treatment evaluation.

Brinkmann R, Podolsky SH (2021).The ‘Personal Equation’ as observer bias, and proposed methods to contain it in Anglo-American medicine. JLL Bulletin: Commentaries on the history of treatment evaluation.

Clarke M (2021).The true meaning of DICE: Don’t Ignore Chance Effects JLL Bulletin: Commentaries on the history of treatment evaluation.

Matthews RAJ (2020).The origins of the treatment of uncertainty in clinical medicine. Part 1: Ancient roots, familiar disputes. JLL Bulletin: Commentaries on the history of treatment evaluation.

Trahair B, Peters L (2020).James Lind’s descendants. 2nd edition (supersedes Peters L 2006). JLL Bulletin: Commentaries on the history of treatment evaluation.

Matthews RAJ (2020).The origins of the treatment of uncertainty in clinical medicine. Part 2: the emergence of probability theory and its limitations. JLL Bulletin: Commentaries on the history of treatment evaluation.

Tröhler U (2020)Probabilistic thinking and the evaluation of therapies, 1700-1900. JLL Bulletin: Commentaries on the history of treatment evaluation.

Johnson A† (2019).Textbooks and other publications on controlled clinical trials, 1948 to 1983. JLL Bulletin: Commentaries on the history of treatment evaluation.

Chalmers I (2019).Doug Altman’s prescience in recognizing the need to reduce biases before tackling imprecision in Systematic Reviews. JLL Bulletin: Commentaries on the history of treatment evaluation.

Mirza RD, Punja S, Vohra S, Guyatt G (2017).The history and development of N of 1 trials. JLL Bulletin: Commentaries on the history of treatment evaluation.

Wartolowska K, Beard DJ, Carr AJ (2017).The use of placebos in controlled trials of surgical interventions: a brief history. JLL Bulletin: Commentaries on the history of treatment evaluation.

Gachelin G, Garner P, Ferroni E, Tröhler U, Chalmers I (2016).Evaluating Cinchona bark and quinine for treating and preventing malaria. JLL Bulletin: Commentaries on the history of treatment evaluation.

Clarke M (2015).History of evidence synthesis to assess treatment effects: personal reflections on something that is very much alive. JLL Bulletin: Commentaries on the history of treatment evaluation.

Altman DG†, Simera I (2015).A history of the evolution of guidelines for reporting medical research: the long road to the EQUATOR Network. JLL Bulletin: Commentaries on the history of treatment evaluation.

Marušić A, Fatović-Ferenčić S (2012).Adoption of the double dummy trial design to reduce observer bias in testing treatments. JLL Bulletin: Commentaries on the history of treatment evaluation.

Kaptchuk TJ (2011).A brief history of the evolution of methods to control observer biases in tests of treatments. JLL Bulletin: Commentaries on the history of treatment evaluation.

Dickersin K, Chalmers I (2010).Recognising, investigating and dealing with incomplete and biased reporting of clinical research: from Francis Bacon to the World Health Organisation. JLL Bulletin: Commentaries on the history of treatment evaluation.

Tröhler U (2010).The introduction of numerical methods to assess the effects of medical interventions during the 18th century: a brief history. JLL Bulletin: Commentaries on the history of treatment evaluation.

O'Rourke K (2006).A historical perspective on meta-analysis: dealing quantitatively with varying study results. JLL Bulletin: Commentaries on the history of treatment evaluation.

Armitage P† (2003).Some recollections of the early years of the Medical Research Council (MRC) Statistical Research Unit. JLL Bulletin: Commentaries on the history of treatment evaluation.

Silverman WA†, Chalmers I (2002).Casting and drawing lots: a time-honoured way of dealing with uncertainty and for ensuring fairness. JLL Bulletin: Commentaries on the history of treatment evaluation.

ALL ARTICLES

BROWSE

ABOUT

COPYRIGHT

FEEDBACK

James Lind Library
Illustrating the development of fair tests of treatments in health care

Show

Glasziou P, Matthews R, Boutron I, Chalmers I, Armitage P† (2023)
The differences and overlaps between ‘explanatory’ and ‘pragmatic’ controlled trials: a historical perspective. JLL Bulletin: Commentaries on the history of treatment evaluation.

Lee A (2022).
The development of network meta-analysis. JLL Bulletin: Commentaries on the history of treatment evaluation.

Brinkmann R, Podolsky SH (2021).
The ‘Personal Equation’ as observer bias, and proposed methods to contain it in Anglo-American medicine. JLL Bulletin: Commentaries on the history of treatment evaluation.

Clarke M (2021).
The true meaning of DICE: Don’t Ignore Chance Effects JLL Bulletin: Commentaries on the history of treatment evaluation.

Matthews RAJ (2020).
The origins of the treatment of uncertainty in clinical medicine. Part 1: Ancient roots, familiar disputes. JLL Bulletin: Commentaries on the history of treatment evaluation.

Trahair B, Peters L (2020).
James Lind’s descendants. 2nd edition (supersedes Peters L 2006). JLL Bulletin: Commentaries on the history of treatment evaluation.

Matthews RAJ (2020).
The origins of the treatment of uncertainty in clinical medicine. Part 2: the emergence of probability theory and its limitations. JLL Bulletin: Commentaries on the history of treatment evaluation.

Tröhler U (2020)
Probabilistic thinking and the evaluation of therapies, 1700-1900. JLL Bulletin: Commentaries on the history of treatment evaluation.

Johnson A† (2019).
Textbooks and other publications on controlled clinical trials, 1948 to 1983. JLL Bulletin: Commentaries on the history of treatment evaluation.

Chalmers I (2019).
Doug Altman’s prescience in recognizing the need to reduce biases before tackling imprecision in Systematic Reviews. JLL Bulletin: Commentaries on the history of treatment evaluation.

Mirza RD, Punja S, Vohra S, Guyatt G (2017).
The history and development of N of 1 trials. JLL Bulletin: Commentaries on the history of treatment evaluation.

Wartolowska K, Beard DJ, Carr AJ (2017).
The use of placebos in controlled trials of surgical interventions: a brief history. JLL Bulletin: Commentaries on the history of treatment evaluation.

Gachelin G, Garner P, Ferroni E, Tröhler U, Chalmers I (2016).
Evaluating Cinchona bark and quinine for treating and preventing malaria. JLL Bulletin: Commentaries on the history of treatment evaluation.

Clarke M (2015).
History of evidence synthesis to assess treatment effects: personal reflections on something that is very much alive. JLL Bulletin: Commentaries on the history of treatment evaluation.

Altman DG†, Simera I (2015).
A history of the evolution of guidelines for reporting medical research: the long road to the EQUATOR Network. JLL Bulletin: Commentaries on the history of treatment evaluation.

Marušić A, Fatović-Ferenčić S (2012).
Adoption of the double dummy trial design to reduce observer bias in testing treatments. JLL Bulletin: Commentaries on the history of treatment evaluation.

Kaptchuk TJ (2011).
A brief history of the evolution of methods to control observer biases in tests of treatments. JLL Bulletin: Commentaries on the history of treatment evaluation.

Dickersin K, Chalmers I (2010).
Recognising, investigating and dealing with incomplete and biased reporting of clinical research: from Francis Bacon to the World Health Organisation. JLL Bulletin: Commentaries on the history of treatment evaluation.

Tröhler U (2010).
The introduction of numerical methods to assess the effects of medical interventions during the 18th century: a brief history. JLL Bulletin: Commentaries on the history of treatment evaluation.

O'Rourke K (2006).
A historical perspective on meta-analysis: dealing quantitatively with varying study results. JLL Bulletin: Commentaries on the history of treatment evaluation.

Armitage P† (2003).
Some recollections of the early years of the Medical Research Council (MRC) Statistical Research Unit. JLL Bulletin: Commentaries on the history of treatment evaluation.

Silverman WA†, Chalmers I (2002).
Casting and drawing lots: a time-honoured way of dealing with uncertainty and for ensuring fairness. JLL Bulletin: Commentaries on the history of treatment evaluation.